. 2022 Jan 4;24(1):19. doi: 10.1208/s12248-021-00644-3
© The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists 2022
This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
Fig. 5.
Application of ML/AI based on various aspects of drug development